Utah Medical Products, Inc. (UTMD)

Utah Medical Products Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	247	306	365	365	307	402
Market Cap Growth	-25.77%	-16.18%	-0.11%	18.97%	-23.57%	29.42%
Enterprise Value	153	213	290	305	256	359
PE Ratio	15.54	18.38	22.14	24.69	28.42	27.26
PS Ratio	5.03	6.09	6.98	7.44	7.28	8.56
PB Ratio	1.93	2.38	3.19	3.41	2.99	3.97
P/FCF Ratio	12.30	14.12	17.93	17.68	15.92	24.31
P/OCF Ratio	11.95	13.72	17.25	17.22	15.24	23.54
EV/Sales Ratio	3.12	4.24	5.55	6.21	6.06	7.66
EV/EBITDA Ratio	6.11	8.05	10.45	11.56	12.14	14.50
EV/EBIT Ratio	7.75	10.61	14.04	15.98	18.47	20.08
EV/FCF Ratio	7.64	9.85	14.26	14.75	13.26	21.74
Debt / Equity Ratio	0.00	0.00	0.00	0.00	0.00	0.00
Debt / EBITDA Ratio	0.01	0.01	0.01	0.02	0.02	0.02
Debt / FCF Ratio	0.01	0.01	0.02	0.02	0.02	0.02
Quick Ratio	17.79	20.44	13.52	17.65	14.69	13.78
Current Ratio	19.57	22.56	15.09	19.54	16.42	15.92
Asset Turnover	0.37	0.38	0.44	0.42	0.40	0.44
Return on Equity (ROE)	13.10%	13.50%	15.00%	13.80%	11.00%	15.40%
Return on Assets (ROA)	12.30%	12.70%	13.80%	12.70%	10.10%	13.90%
Return on Capital (ROIC)	10.50%	10.80%	13.77%	13.62%	10.37%	14.31%
Earnings Yield	6.64%	5.44%	4.52%	4.05%	3.52%	3.67%
FCF Yield	8.13%	7.08%	5.58%	5.66%	6.28%	4.11%
Dividend Yield	1.72%	1.40%	1.20%	2.90%	1.30%	1.00%
Payout Ratio	26.67%	25.90%	25.70%	70.50%	38.10%	27.90%
Buyback Yield / Dilution	0.28%	-0.05%	0.64%	-0.29%	2.17%	0.35%
Total Shareholder Return	1.99%	1.35%	1.84%	2.61%	3.47%	1.35%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).